Busulfan Pharmacokinetics and Precision Dosing: Are Patients with Fanconi Anemia Different?.
Mehta, PA; Emoto, C; Fukuda, T; Seyboth, B; Teusink-Cross, A; Davies, SM; Wilhelm, J; Fuller, K; Vinks, AA; Boulad, F.
Biology of Blood and Marrow Transplantation.
2019;
25:2416-2421.
Unique Challenges of Hematopoietic Cell Transplantation in Adolescent and Young Adults with Hematologic Malignancies.
Mehta, PA; Rotz, SJ; Majhail, NS.
Biology of Blood and Marrow Transplantation.
2018;
24:e11-e19.
Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study.
Dvorak, CC; Satwani, P; Stieglitz, E; Cairo, MS; Dang, H; Pei, Q; Gao, Y; Wall, D; Mazor, T; Olshen, AB; et al.
Pediatric Blood and Cancer.
2018;
65.
Micafungin antifungal prophylaxis in children undergoing HSCT: can we give higher doses, less frequently? A pharmacokinetic study.
Chandra, S; Fukuda, T; Mizuno, K; Davies, SM; Teusink-Cross, A; Tarin, R; Marsh, RA; Vinks, AA; Mehta, PA.
Journal of Antimicrobial Chemotherapy.
2018;
73:1651-1658.
Ruxolitinib for the treatment of chronic GVHD and overlap syndrome in children and young adults.
Wang, YM; Teusink-Cross, A; Elborai, Y; Krupski, MC; Nelson, AS; Grimley, MS; Flannery, A; Mehta, PA; Bleesing, JJ; Chandra, S; et al.
Transplantation.
2021.
Human Papillomavirus Oral- and Sero- Positivity in Fanconi Anemia.
Sauter, SL; Zhang, X; Romick-Rosendale, L; Wells, SI; Myers, KC; Brusadelli, MG; Poff, CB; Brown, DR; Panicker, G; Unger, ER; et al.
Cancers.
2021;
13.
298 Ruxolitinib for the Treatment of Chronic GVHD in Children and Young Adults.
Wang, YM; Teusink-Cross, A; Myers, KC; Davies, SM; Kumar, A; Chandra, S; Grimley, MS; Flannery, A; Krupski, MC; Nelson, AS; et al.
2021;
27:s257-s258.
Paperspray Ionization Mass Spectrometry as a Tool for Predicting Real-Time Optimized Dosing of the Chemotherapeutic Drug Melphalan.
Zhao, J; Sharat, C; Mehta, PA; Mizuno, K; Vinks, AA; Setchell, KD R.
Journal of Applied Laboratory Medicine.
2021.
The Impact of Donor Type on Outcomes and Cost of Allogeneic Hematopoietic Cell Transplantation for Pediatric Leukemia: A Merged Center for International Blood and Marrow Transplant Research and Pediatric Health Information System Analysis.
Arnold, SD; Brazauskas, R; He, N; Li, Y; Hall, M; Atsuta, Y; Dalal, J; Hahn, T; Khera, N; Bonfim, C; et al.
Biology of Blood and Marrow Transplantation.
2020;
26:1747-1756.
Comparison of the clinical phenotype and haematological course of siblings with Fanconi anaemia.
Jung, M; Mehta, PA; Jiang, CS; Rosti, RO; Usleaman, G; da Rosa, JM C; Lach, FP; Goodridge, E; Auerbach, AD; Davies, SM; et al.
British Journal of Haematology.
2020.